SK Pharmteco announced that it will invest more than $200 million in the US to expand small molecule and peptide production capacity.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.